Yujie Liu

Years Active: 2022-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Li Kang, Yujie Liu, Jianzhong He, Yaling Wang, Mengyang Xue, Xin Wu, Zhen Wang, Yunpeng Zhang, Manyu Chu, Jialun Li, Wei Wei, Jiwen Li, En-Min Li, Lujian Liao, Jianru Xiao, Rong Zhang, Li-Yan Xu, Jiemin Wong
GSK3β-driven SOX2 overexpression is a targetable vulnerability in esophageal squamous cell carcinoma. Oncogene (2023)
Yujie Liu, Ao Leng, Lin Li, Bo Yang, Shihui Shen, Hui Chen, Enhao Zhu, Qiyue Xu, Xiaoyu Ma, Peilin Shi, Yun Liu, Tielong Liu, Lei Li, Kun Li, Dan Zhang, Jianru Xiao
AMTB, a TRPM8 antagonist, suppresses growth and metastasis of osteosarcoma through repressing the TGFβ signaling pathway. Cell death & disease 13 (3) (2022)

Yujie Liu.css-eqlu8i{font-size:small;padding-left:4px;}